Carl Steinbeißer
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Introducing PIONEER: a project to harness big data in prostate cancer research(2020)39 cited
- → How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis(2022)15 cited
- → Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data(2023)15 cited
- → Evaluating a novel approach to stimulate open science collaborations: a case series of “study-a-thon” events within the OHDSI and European IMI communities(2022)9 cited
- → PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research(2024)7 cited
- → Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research(2020)5 cited
- → Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI’s “big data for better outcomes” program(2023)5 cited
- → Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform(2024)4 cited
- → Research Protocol for an Observational Health Data Analysis to Assess the Long-term Outcomes of Prostate Cancer Patients Undergoing Non-Interventional Management (i.e., Watchful Waiting) and the Impact of Comorbidities and Life Expectancy – PIONEER IMI’s “Big Data for Better Outcomes” program(2021)3 cited
- → 1796P Real-world analysis of metastatic hormone-sensitive prostate cancer: Are randomized clinical trials more trustworthy? Insights from PIONEER, the European network of excellence for big data in prostate cancer(2023)3 cited